JP2018529683A - 胎盤細胞を使用した糖尿病性末梢神経障害の処置 - Google Patents

胎盤細胞を使用した糖尿病性末梢神経障害の処置 Download PDF

Info

Publication number
JP2018529683A
JP2018529683A JP2018513527A JP2018513527A JP2018529683A JP 2018529683 A JP2018529683 A JP 2018529683A JP 2018513527 A JP2018513527 A JP 2018513527A JP 2018513527 A JP2018513527 A JP 2018513527A JP 2018529683 A JP2018529683 A JP 2018529683A
Authority
JP
Japan
Prior art keywords
cells
placental
isolated
cell
placental cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018513527A
Other languages
English (en)
Japanese (ja)
Inventor
フィッシュコフ，スティーブン，エー．
チットカーラ，デネッシュ
Original Assignee
セルラリティ インコーポレイテッド
セルラリティ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セルラリティ インコーポレイテッド, セルラリティ インコーポレイテッド filed Critical セルラリティ インコーポレイテッド
Publication of JP2018529683A publication Critical patent/JP2018529683A/ja
Priority to JP2021133914A priority Critical patent/JP2021183635A/ja
Priority to JP2023145722A priority patent/JP2023171769A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2018513527A 2015-09-15 2016-09-14 胎盤細胞を使用した糖尿病性末梢神経障害の処置 Pending JP2018529683A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021133914A JP2021183635A (ja) 2015-09-15 2021-08-19 胎盤細胞を使用した糖尿病性末梢神経障害の処置
JP2023145722A JP2023171769A (ja) 2015-09-15 2023-09-08 胎盤細胞を使用した糖尿病性末梢神経障害の処置

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562218885P 2015-09-15 2015-09-15
US62/218,885 2015-09-15
PCT/US2016/051571 WO2017048741A1 (en) 2015-09-15 2016-09-14 Treatment of diabetic peripheral neuropathy using placental cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021133914A Division JP2021183635A (ja) 2015-09-15 2021-08-19 胎盤細胞を使用した糖尿病性末梢神経障害の処置

Publications (1)

Publication Number Publication Date
JP2018529683A true JP2018529683A (ja) 2018-10-11

Family

ID=58289824

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018513527A Pending JP2018529683A (ja) 2015-09-15 2016-09-14 胎盤細胞を使用した糖尿病性末梢神経障害の処置
JP2021133914A Pending JP2021183635A (ja) 2015-09-15 2021-08-19 胎盤細胞を使用した糖尿病性末梢神経障害の処置
JP2023145722A Pending JP2023171769A (ja) 2015-09-15 2023-09-08 胎盤細胞を使用した糖尿病性末梢神経障害の処置

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021133914A Pending JP2021183635A (ja) 2015-09-15 2021-08-19 胎盤細胞を使用した糖尿病性末梢神経障害の処置
JP2023145722A Pending JP2023171769A (ja) 2015-09-15 2023-09-08 胎盤細胞を使用した糖尿病性末梢神経障害の処置

Country Status (17)

Country Link
US (2) US20180264048A1 (enExample)
EP (2) EP3957315A1 (enExample)
JP (3) JP2018529683A (enExample)
KR (1) KR20180051631A (enExample)
CN (1) CN108367028A (enExample)
AU (1) AU2016323120A1 (enExample)
BR (1) BR112018005014B1 (enExample)
CA (1) CA2998759A1 (enExample)
CO (1) CO2018003759A2 (enExample)
EA (1) EA201890720A1 (enExample)
IL (2) IL281185B2 (enExample)
MX (1) MX2018003275A (enExample)
MY (1) MY203748A (enExample)
NZ (1) NZ740663A (enExample)
SG (1) SG10201912572VA (enExample)
WO (1) WO2017048741A1 (enExample)
ZA (1) ZA201801708B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118284725A (zh) 2021-11-10 2024-07-02 三菱化学株式会社 碳纤维、碳纤维束和碳纤维束的制造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014516988A (ja) * 2011-06-01 2014-07-17 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190556A (en) 1991-03-19 1993-03-02 O.B. Tech, Inc. Cord cutter sampler
US5372581A (en) 1993-07-21 1994-12-13 Minneapolis Children's Services Corporation Method and apparatus for placental blood collection
KR100619611B1 (ko) 1999-04-16 2006-09-01 더블유엠. 마쉬 라이스 유니버시티 작용화 폴리(프로필렌 푸마레이트) 및 폴리(프로필렌푸마레이트-코-에틸렌 글리콜
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
EP2305795B1 (en) 2000-12-06 2019-07-03 Celularity, Inc. Method of collecting placental stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
WO2002064755A2 (en) 2001-02-14 2002-08-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
AU2002243980B2 (en) 2001-02-14 2007-08-23 Robert J. Hariri Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
US7255729B2 (en) 2003-05-30 2007-08-14 Noritake Co., Limited Porous cylindrical-body module, structure for supporting porous cylindrical bodies, and method for fastening a supporting member
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
EP2471903B1 (en) 2005-12-29 2018-02-14 Anthrogenesis Corporation Placental stem cell populations
US9598669B2 (en) 2005-12-29 2017-03-21 Anthrogenesis Corporation Composition for collecting placental stem cells and methods of using the composition
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
PT2556145T (pt) * 2010-04-07 2016-10-25 Anthrogenesis Corp Angiogénese usando células estaminais placentárias

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014516988A (ja) * 2011-06-01 2014-07-17 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRONTIERS IN ENDOCRINOLOGY, vol. 5, JPN6020031662, 2014, pages 45 - 1, ISSN: 0004489260 *

Also Published As

Publication number Publication date
US20220072063A1 (en) 2022-03-10
MX2018003275A (es) 2018-05-16
MY203748A (en) 2024-07-17
EP3349771A4 (en) 2019-04-24
IL258048A (en) 2018-05-31
CN108367028A (zh) 2018-08-03
AU2016323120A1 (en) 2018-04-12
SG10201912572VA (en) 2020-02-27
CO2018003759A2 (es) 2018-12-14
EP3349771A1 (en) 2018-07-25
CA2998759A1 (en) 2017-03-23
IL281185B2 (en) 2024-05-01
NZ740663A (en) 2022-12-23
JP2021183635A (ja) 2021-12-02
WO2017048741A1 (en) 2017-03-23
IL281185B1 (en) 2024-01-01
BR112018005014B1 (pt) 2022-03-22
JP2023171769A (ja) 2023-12-05
US20180264048A1 (en) 2018-09-20
BR112018005014A2 (enExample) 2018-10-02
EP3957315A1 (en) 2022-02-23
EA201890720A1 (ru) 2018-09-28
IL281185A (en) 2021-04-29
ZA201801708B (en) 2019-01-30
KR20180051631A (ko) 2018-05-16

Similar Documents

Publication Publication Date Title
JP2016192966A (ja) 胎盤幹細胞を用いる血管形成
US20210230537A1 (en) Angiogenesis using stimulated placental stem cells
JP2023022018A (ja) 急性腎損傷の治療における胎盤幹細胞の使用
JP2022184911A (ja) 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
JP2023171769A (ja) 胎盤細胞を使用した糖尿病性末梢神経障害の処置
US20230302058A1 (en) Treatment of lymphedema and related conditions using placental adherent cells
HK40058728A (en) Treatment of diabetic peripheral neuropathy using placental cells
HK1220135B (en) Use of placental stem cells in treatment of acute kidney injury

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190912

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200901

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201125

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210129

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210420